Who owns AKARI THERAPEUTICS PLC SPONSORED?
- Ticker: AKTX
- CUSIP Number: 00972g207
Tip: Access positions for across all investors
Analyze quarterly positions in Akari Therapeutics Plc Sponsored with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Akari Therapeutics Plc Sponsored stock
Who bought or sold AKARI THERAPEUTICS PLC SPONSORED this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Cresset Asset Management | 823k | $238k | 0% | Dec 2025 |
|
| Palo Alto Investors | 146k | $42k | 0% | Dec 2025 |
|
| XTX Topco | 49k | $14k | 100% | Dec 2025 |
|
| HPM Partners | 24k | $6.8k | 0% | Dec 2025 |
|
| Intl Fcstone | 21k | $6.2k | 100% | Dec 2025 |
|
| Skyview Financial Group | 21k | $5.9k | 100% | Dec 2025 |
|
| IFP Advisors | 7.3k | $877.250000 | 100% | Mar 2026 |
|
| Goss Wealth Management | 6.8k | $2.0k | 0% | Dec 2025 |
|
Who sold out of Akari Therapeutics Plc Sponsored?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Warberg Asset Management | Dec 2025 | 308k | $89k |
| HighTower Advisors | Dec 2025 | 79k | $23k |
| Jane Street | Dec 2025 | 72k | $21k |
| CWA Asset Management | Dec 2025 | 55k | $16k |
| UBS Group | Dec 2025 | 33k | $9.5k |
| Virtu Financial | Sep 2025 | 23k | $22k |
| Two Sigma Securities | Sep 2025 | 20k | $20k |
| Independent Advisor Alliance | Dec 2025 | 17k | $4.9k |